HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy A McNamara Selected Research

Drug Resistant Epilepsy

1/2022Surgical evaluation in children <3 years of age with drug-resistant epilepsy: Patient characteristics, diagnostic utilization, and potential for treatment delays.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nancy A McNamara Research Topics

Disease

9Dry Eye Syndromes (Dry Eye Syndrome)
01/2020 - 01/2008
6Inflammation (Inflammations)
11/2019 - 01/2008
4Metaplasia
04/2012 - 01/2008
3Epilepsy (Aura)
01/2021 - 10/2013
3Lung Neoplasms (Lung Cancer)
09/2014 - 01/2012
2Seizures (Absence Seizure)
01/2021 - 01/2021
1Drug Resistant Epilepsy
01/2022
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Epileptic Syndromes
01/2020
1Lennox Gastaut Syndrome
01/2020
1Cicatrix (Scar)
11/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2016
1Adenocarcinoma
12/2016
1Acne Vulgaris
09/2015
1Meibomian Gland Dysfunction
09/2015
1Uveitis
06/2014
1Autoimmune Diseases (Autoimmune Disease)
04/2014
1Carcinogenesis
06/2013
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2012
1Hyperplasia
04/2012
1Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
08/2011
1Keratoconjunctivitis Sicca
03/2010
1Sialadenitis
03/2010
1Acquired Immunodeficiency Syndrome (AIDS)
01/2003

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2016 - 01/2008
3Glycoproteins (Glycoprotein)IBA
01/2020 - 01/2003
3Delta CateninIBA
12/2016 - 01/2012
3MucinsIBA
09/2015 - 01/2003
3Biomarkers (Surrogate Marker)IBA
09/2010 - 01/2008
3Cornified Envelope Proline-Rich ProteinsIBA
09/2010 - 01/2008
2Interleukin-1 (Interleukin 1)IBA
09/2015 - 09/2010
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2012 - 09/2010
2CytokinesIBA
05/2010 - 08/2008
1Pharmaceutical PreparationsIBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1CannabidiolIBA
01/2020
1Valproic Acid (Depakote)FDA LinkGeneric
01/2020
1Peptides (Polypeptides)IBA
11/2019
1CollagenIBA
11/2019
1Vitamin DFDA LinkGeneric
11/2017
1SteroidsIBA
01/2017
1Ion Channels (Ion Channel)IBA
01/2017
1N-formyl-13-dihydrocarminomycin (NFD)IBA
10/2016
1Isotretinoin (Accutane)FDA LinkGeneric
09/2015
1Biological ProductsIBA
09/2015
1SmokeIBA
09/2014
1Retinaldehyde (Retinal)IBA
06/2014
1tear proteinsIBA
08/2011
1InterleukinsIBA
09/2010
1Immunologic Factors (Immunomodulators)IBA
09/2010
1SS-B antibodiesIBA
03/2010
1SS-A antibodiesIBA
03/2010
1Fluorescein (Funduscein)FDA LinkGeneric
03/2010
1Messenger RNA (mRNA)IBA
01/2008

Therapy/Procedure

5Therapeutics
11/2019 - 09/2010
1Treatment Delay
01/2022
1Duration of Therapy
01/2021
1Induced Hypothermia
01/2021
1Refractive Surgical Procedures
11/2017
1Topical Administration
07/2014
1Ketogenic Diet
10/2013
1Drug Therapy (Chemotherapy)
01/2012